Thyrocare Technologies Limited (BOM: 539871)
India flag India · Delayed Price · Currency is INR
976.40
+28.55 (3.01%)
At close: Nov 14, 2024

Thyrocare Technologies Company Description

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India.

It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases.

Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests.

The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products.

Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Thyrocare Technologies Limited
Country India
Founded 1996
Industry Medical Laboratories
Employees 1,693
CEO Rahul Guha

Contact Details

Address:
D/37-3, TTC Industrial Area
Navi Mumbai, 400703
India
Phone 91 22 3090 0000
Website thyrocare.com

Stock Details

Ticker Symbol 539871
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 8071

Key Executives

Name Position
Rahul Guha Chief Executive Officer
Alok Jagnani Chief Financial Officer
K. KallathiKumar Chief Operating Officer
Pratik Hire Head of Investor Relations